by EpicentRx | Sep 1, 2023 | Blog
Current treatments for diabetes include insulin, Glucotrol, Januvia, Metformin, Acarbose, Ozempic, Farxiga, Byetta, and potentially We Will Rock you by Queen. Also, potentially the soundtrack to the Avengers movie. Huh? Say again?? Ok, so diabetes is a disease where...
by EpicentRx | Sep 1, 2023 | Conferences
November 2023; Boston, Massachusetts Oral Presentation: The Exploring the Development of RRx-001: the NLRP3 Small Molecule Inhibitor for a Variety of Inflammatory Diseases
by EpicentRx | Sep 1, 2023 | Conferences
November 2023; Washington D.C. Oral Presentation: The CNS-permeable NLRP3 inhibitor RRx-001 is neuroprotective in experimental models of Parkinson’s disease
by EpicentRx | Sep 1, 2023 | Conferences
June 2023; Chicago, Illinois Poster: RRX-001 Initial results from a first in human dose escalation trial of a novel immune stimulating oncolytic adenovirus, AdAPT-001 TGF-ß Trap (NCT04673942) Poster: RRX-001, KEVLARx: A phase 2b, multi-institutional, randomized,...
